Harbin Shengtai Biopharmaceutical

Harbin Shengtai Biopharmaceutical Co., Ltd., also known as Harbin Sanctity Pharmaceutical, is a prominent Chinese pharmaceutical company and a wholly-owned subsidiary of Tonghua Golden-Horse Pharmaceutical Group. Founded in 1996 and headquartered in Harbin, the company specializes in the research, development, and manufacturing of biopharmaceuticals, chemical drugs, and traditional Chinese medicines (TCM). Its extensive product portfolio includes nearly 100 varieties, with key offerings such as Calcium Gluconate Oral Solution, Calf Blood Deproteinized Extract Injection, and Bone Melon Extract Injection. The company maintains large-scale, GMP-certified production facilities and focuses on therapeutic areas including cardiovascular, cerebrovascular, respiratory, and orthopedic health. Following its acquisition in 2015, it has continued to operate as a core manufacturing and R&D hub within its parent group's pharmaceutical ecosystem.